Virtu Financial LLC Corcept Therapeutics Inc Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $182,878 - $281,351	8,324 New	8,324 $227,000
Q2 2020 Aug 07, 2020	SELL	$11.0 - $18.26 $244,255 - $405,463	-22,205 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$12.06 - $16.96 $267,792 - $376,596	22,205 New	22,205 $269,000
Q1 2019 Apr 12, 2019	SELL	$10.03 - $15.71 $136,879 - $214,394	-13,647 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$11.29 - $17.19 $154,074 - $234,591	13,647 New	13,647 $182,000
Q2 2018 Jul 30, 2018	SELL	$15.3 - $19.69 $162,486 - $209,107	-10,620 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$15.3 - $19.69 $29,620 - $38,119	-1,936 Reduced 15.42%	10,620 $167,000
Q1 2018 May 14, 2018	BUY	$14.59 - $25.5 $183,192 - $320,178	12,556 New	12,556 $207,000

361

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.28B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.